A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AS PRIMARY TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER COMPARED TO CHEMORADIATION ALONE: THE OUTBACK TRIAL (ANZGOG 0902/GOG-0274/RTOG 1174)
The aim of the study is to test the potential benefit of the addition of adjuvant chemotherapy following completion of primary chemoradiation for patients with locally advanced cervical cancer.
Study phase: III
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
1. Adult women with locally advanced cervical cancer suitable for primary treatment with chemoradiation with curative intent.
2. Stage IB1 and node positive, IB2, II, IIIB or IVA disease
Primary disease category: Cancer
Sponsor: GOG/NCI
Protocol number: ANZGOG 0902/GOG-0274/RTOG 1174
Projected enrollment dates: November 2015 to October 2018
Official study title: A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AS PRIMARY TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER COMPARED TO CHEMORADIATION ALONE: THE OUTBACK TRIAL (ANZGOG 0902/GOG-0274/RTOG 1174)